Company news

Ackermans & Van Haaren Nv (EURONEXT:ACKB) news

Every Ackermans & Van Haaren Nv press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Ackermans & Van Haaren Nv stock analysis →

Press releases & updates

Ackermans & van Haaren publishes convening notice for the Extraordinary Shareholder Meeting of October 15, 2026

September 14, 2026

Ackermans & van Haaren recorded a strong first half of 2026, with a net profit of EUR 339.6 million (+24%).

August 28, 2026

Ackermans & van Haaren enters the salmon aquaculture industry through a EUR 93 million investment in Grieg Aqua

August 28, 2026

Ackermans & van Haaren: all items on the agenda of the ASM approved, incl. gross dividend of €4.60 per share

May 26, 2026

Ackermans & van Haaren : Interim statement 1Q2026 Presentation

May 21, 2026

Biotalys Obtains Subscription Commitments for EUR 12.05 Million through a Private Placement of New Shares with Current Investors

May 6, 2026

Ackermans & van Haaren : sluit een succesvol jaar af met een nettowinst van 593 miljoen euro (+29%)

February 27, 2026

Ackermans & van Haaren ends a successful year 2025 with a net profit of 593 million euros (+29%)

February 27, 2026

DISCO Pharmaceuticals Appoints Mark Manfredi as CEO and Announces Final Close of €36 Million Seed Financing

December 11, 2025

Ackermans & van Haaren Trading Update 3Q2025: Excellent results of core participations, FY2025 Outlook confirmed

November 21, 2025

PUBLICATION OF ATRANSPARENCY NOTIFICATION - ACKERMANS & VAN HAAREN

November 3, 2025

Ackermans & van Haaren : investit 22 millions d'euros dans VKC Nuts

September 25, 2025

Ackermans & van Haaren : investeert 22 miljoen euro in VKC Nuts

September 25, 2025

Ackermans & van Haaren invests 22 million euros in VKC Nuts

September 25, 2025

Nokia expands defense portfolio with two advanced tactical communication solutions

September 9, 2025

Ackermans & van Haaren : soutient le tour de financement de série B de 55 millions d’euros de MRM Health

September 4, 2025

Ackermans & van Haaren : ondersteunt de serie B-financieringsronde van 55 miljoen euro van MRM Health

September 4, 2025

Ackermans & van Haaren supports MRM Health’s Series B financing round of 55 million euros

September 4, 2025

Ackermans & van Haaren : s’engage à hauteur de 20 millions de dollars dans le deuxième fonds de Venturi Partners

September 2, 2025

Ackermans & van Haaren : investeert 20 miljoen US dollar in het tweede fonds van Venturi Partners

September 2, 2025

Ackermans & van Haaren commits 20 million US dollars to the second fund of Venturi Partners

September 2, 2025

Ackermans & van Haaren: Halfjaarresultaten 2025

August 29, 2025

Ackermans & van Haaren : Résultats semestriels 2025

August 29, 2025

Ackermans & van Haaren: First-Half 2025 Results

August 29, 2025

Ackermans & van Haaren: the General Shareholders' Meeting approves all proposed resolutions by a vast majority

May 26, 2025

Ackermans & van Haaren (Trading Update Q1 2025): AvH meldt solide start van het jaar en bevestigt jaarprognose

May 22, 2025

Ackermans & van Haaren (Trading Update Q1 2025): AvH reports solid start to the year and confirms guidance

May 22, 2025

Ackermans & van Haaren: publication of a transparency notification

April 4, 2025